Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer.

Saved in:
Bibliographic Details
Title: Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer.
Authors: Li J; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania., Yuan S; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania., Norgard RJ; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania., Yan F; Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Sun YH; Center for RNA Biology, Department of Biochemistry and Biophysics, Department of Biology, University of Rochester Medical Center, Rochester, New York., Kim IK; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania., Merrell AJ; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania., Sela Y; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania., Jiang Y; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania., Bhanu NV; Penn Epigenetics Institute, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania., Garcia BA; Penn Epigenetics Institute, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania., Vonderheide RH; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, Pennsylvania.; Institute for Immunology, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Blanco A; Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Stanger BZ; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. bstanger@upenn.edu.; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
Source: Cancer discovery [Cancer Discov] 2021 Mar; Vol. 11 (3), pp. 736-753. Date of Electronic Publication: 2020 Nov 06.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first